The current approach, which initiates medications and escalates to mechanical circulatory support, has not resulted in a ...

Advances in critical care therapies for patients with cardiogenic shock (CS), including temporary mechanical circulatory support and multidisciplinary shock teams, have led to improved survival to ...

Hospitals with a higher volume of percutaneous microaxial ventricular assist device implantation in the US have fewer deaths among cardiogenic shock patients.

Laboratories Inc., the biotechnology firm's stock (NASDAQ: WINT) has recorded a new 52-week low, dipping to $0.21. According ...